Benefits and limitations of testing for resistance to HIV drugsRICHMAN, Douglas D.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 4, pp 555-557, issn 0305-7453, 3 p.Article

HIV chemotherapy : AIDSRICHMAN, Douglas D.Nature (London). 2001, Vol 410, Num 6831, pp 995-1001, issn 0028-0836Article

Clinical management of hepatitis B virus monoinfection and coinfection with HIVRICHMAN, Douglas D.Antiviral therapy (London). 2007, Vol 12, issn 1359-6535, 60 p., SUP3Serial Issue

Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitorRICHMAN, Douglas D.Antiviral therapy (London). 2001, Vol 6, Num 2, pp 83-88, issn 1359-6535Conference Paper

Antiviral drug resistanceRICHMAN, Douglas D.Antiviral research. 2006, Vol 71, Num 2-3, pp 117-121, issn 0166-3542, 5 p.Article

Antiretroviral therapy in practice : symposium on zidovudineLüTHY, Ruedi; RICHMAN, Douglas D.Drugs (Basel). 1995, Vol 49, issn 0012-6667, 45 p., SUP1Conference Proceedings

Minority Variants of Drug-Resistant HIVGIANELLA, Sara; RICHMAN, Douglas D.The Journal of infectious diseases. 2010, Vol 202, Num 5, pp 657-666, issn 0022-1899, 10 p.Article

Diagnosis, diagnostic tests and monitoring of hepatitis B virus in monoinfected and HIV-coinfected patientsTHIO, Chloe L.Antiviral therapy (London). 2007, Vol 12, issn 1359-6535, H25-H31, SUP3Article

Rates of emergence of HIV drug resistance in resource―limited settings: a systematic reviewSTADELI, Kathryn M; RICHMAN, Douglas D.Antiviral therapy (London). 2013, Vol 18, Num 1, pp 115-123, issn 1359-6535, 9 p.Article

The epidemiology, natural history and prevention of hepatitis B : implications of HIV coinfectionMCGOVERN, Barbara H.Antiviral therapy (London). 2007, Vol 12, issn 1359-6535, H3-H13, SUP3Article

Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIVLOCARNINI, Stephen; WARNER, Nadia.Antiviral therapy (London). 2007, Vol 12, issn 1359-6535, H15-H23, SUP3Article

Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC)PORTEGIES, P.Drugs (Basel). 1995, Vol 49, pp 25-31, issn 0012-6667, SUP1Conference Paper

Combination antiretroviral therapy : back to the futureLANGE, J.Drugs (Basel). 1995, Vol 49, pp 32-37, issn 0012-6667, SUP1Conference Paper

Prevention of maternal HIV transmission : practical guidelinesROUZIOUX, C.Drugs (Basel). 1995, Vol 49, pp 17-24, issn 0012-6667, SUP1Conference Paper

Treatment of chronic hepatitis BLOOMBA, Rohit; LIANG, T. Jake.Antiviral therapy (London). 2007, Vol 12, issn 1359-6535, H33-H41, SUP3Article

Special considerations and treatment of patients with HBV-HIV coinfectionDIETERICH, Douglas T.Antiviral therapy (London). 2007, Vol 12, issn 1359-6535, H43-H51, SUP3Article

Confronting the emergence of drug-resistant HIV type 1 : Impact of antiretroviral therapy on individual and population resistanceDAAR, Eric S; RICHMAN, Douglas D.AIDS research and human retroviruses. 2005, Vol 21, Num 5, pp 343-357, issn 0889-2229, 15 p.Article

The value of the CD4+ count of 500 cells/μlVOLBERDING, P.Drugs (Basel). 1995, Vol 49, pp 4-8, issn 0012-6667, SUP1Conference Paper

HIV superinfectionSMITH, Davey M; RICHMAN, Douglas D; LITTLE, Susan J et al.The Journal of infectious diseases. 2005, Vol 192, Num 3, pp 438-444, issn 0022-1899, 7 p.Article

Early versus delayed treatment of HIV infection : zidovudine should be given before symptoms developRICHMAN, D. D; HAVLIR, D.Drugs (Basel). 1995, Vol 49, pp 9-16, issn 0012-6667, SUP1Conference Paper

Evaluation of a Highly Sensitive Qualitative Human Immunodeficiency Virus Type 1 (HIV-1) RNA Assay for Detection of HIV-1 SuppressionNUGENT, C. Thomas; NODELMAN, Vladislav; GIACHETTI, Cristina et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 3, pp 833-836, issn 0095-1137, 4 p.Article

Consensus Symposium on Combined Antiviral TherapyKERN, Earl R; RICHMAN, Douglas D.Antiviral research. 1996, Vol 29, Num 1, issn 0166-3542, 123 p.Conference Proceedings

Innovative combination clinical trial designs/patient compliance : A community perspectiveBAHLMAN, W.Antiviral research. 1996, Vol 29, Num 1, pp 115-117, issn 0166-3542Conference Paper

HIV-1 Expression Within Resting CD4⁺ T Cells After Multiple Doses of VorinostatARCHIN, Nancy M; BATESON, Rosalie; RICHMAN, Douglas D et al.The Journal of infectious diseases. 2014, Vol 210, Num 5, pp 728-735, issn 0022-1899, 8 p.Article

Associations between Virologic and Immunologic Dynamics in Blood and in the Male Genital TractGIANELIA, Sara; STRAIN, Matthew C; ROUGHT, Steffney E et al.Journal of virology. 2012, Vol 86, Num 3, pp 1307-1315, issn 0022-538X, 9 p.Article